Memantine Synthon 10 mg, tabletten

Riik: Holland

keel: hollandi

Allikas: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

Osta kohe

Infovoldik Infovoldik (PIL)
21-09-2022
Toote omadused Toote omadused (SPC)
13-02-2019

Toimeaine:

MEMANTINEHYDROCHLORIDE 10 mg/stuk SAMENSTELLING overeenkomend met ; MEMANTINE 8,3 mg/stuk

Saadav alates:

Synthon B.V. Microweg 22 6545 CM NIJMEGEN

ATC kood:

N06DX01

INN (Rahvusvaheline Nimetus):

MEMANTINEHYDROCHLORIDE 10 mg/stuk SAMENSTELLING overeenkomend met ; MEMANTINE 8,3 mg/stuk

Ravimvorm:

Filmomhulde tablet

Koostis:

CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; LACTOSE 1-WATER ; MACROGOL 4000 ; MAGNESIUMSTEARAAT (E 470b) ; SILICIUMDIOXIDE (E 551) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171), CELLULOSE, MICROKRISTALLIJN (E 460) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; LACTOSE 1-WATER ; MACROGOL 4000 ; MAGNESIUMSTEARAAT (E 470b) ; SILICIUMDIOXIDE (E 551) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171),

Manustamisviis:

Oraal gebruik

Terapeutiline ala:

Memantine

Toote kokkuvõte:

Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); HYPROMELLOSE (E 464); LACTOSE 1-WATER; MACROGOL 4000; MAGNESIUMSTEARAAT (E 470b); SILICIUMDIOXIDE (E 551); TALK (E 553 B); TITAANDIOXIDE (E 171);

Loa andmise kuupäev:

1900-01-01

Infovoldik

                                M1.3.1_03.MMN.hcl.tab.101.04.NL.2697.01
1.3.1
Package Leaflet
PACKAGE LEAFLET: INFORMATION FOR THE USER
MEMANTINE SYNTHON 10 MG, TABLETTEN
MEMANTINE SYNTHON 20 MG, TABLETTEN
MEMANTINE SYNTHON 5 MG + 10 MG +15 MG + 20 MG, TABLETTEN
memantine hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Memantine Synthon is and what it is used for
2.
What you need to know before you take Memantine Synthon
3.
How to take Memantine Synthon
4.
Possible side effects
5.
How to store Memantine Synthon
6.
Contents of the pack and other information
1.
WHAT MEMANTINE SYNTHON IS AND WHAT IT IS USED FOR
HOW DOES MEMANTINE SYNTHON WORK
Memantine Synthon contains the active substance memantine
hydrochloride.
It belongs to a group of medicines known as anti-dementia medicines.
Memory loss in Alzheimer’s disease is due to a disturbance of
message
signals in the brain.
The brain contains so-called N-methyl-D-aspartate (NMDA)-receptors
that
are involved in transmitting nerve signals important in learning and
memory.
Memantine Synthon belongs to a group of medicines called NMDA-receptor
antagonists. Memantine Synthon acts on these NMDA-receptors improving
the transmission of nerve signals and the memory.
WHAT IS MEMANTINE SYNTHON USED FOR
Memantine Synthon is used for the treatment of patients with moderate
to
severe Alzheimer’s disease.
M1.3.1_03.MMN.hcl.tab.101.04.NL.2697.01
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEMANTINE SYNTHON
DO NOT TAKE MEMANTINE SYNTHON

if you are ALLERGIC TO MEMANTINE HY
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                1/12
M1.3.1_01.MMN.hcl.tab.101.04.NL.2697.01
1
NAME OF THE MEDICINAL PRODUCT
Memantine Synthon 10 mg, tabletten
Memantine Synthon 20 mg, tabletten
Memantine Synthon 5 mg + 10 mg +15 mg + 20 mg, tabletten
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 10 mg film-coated tablet contains 10 mg of memantine
hydrochloride equivalent to 8.31
mg memantine.
Excipient(s) with known effect: each tablet contains 144.32 mg lactose
(as monohydrate).
Each 20 mg film-coated tablet contains 20 mg of memantine
hydrochloride equivalent to 16.62
mg memantine.
Excipient(s) with known effect: each tablet contains 288.63 mg lactose
(as monohydrate).
Each 5 mg film-coated tablet contains 5 mg of memantine hydrochloride
equivalent to 4.15 mg
memantine.
Excipient(s) with known effect: each tablet contains 72.16 mg lactose
(as monohydrate).
Each 10 mg film-coated tablet contains 10 mg of memantine
hydrochloride equivalent to 8.31
mg memantine.
Excipient(s) with known effect: each tablet contains 144.32 mg lactose
(as monohydrate).
Each 15 mg film-coated tablet contains 15 mg of memantine
hydrochloride equivalent to 12.46
mg memantine.
Excipient(s) with known effect: each tablet contains 216.48 mg lactose
(as monohydrate).
Each 20 mg film-coated tablet contains 20 mg of memantine
hydrochloride equivalent to 16.62
mg memantine.
Excipient(s) with known effect: each tablet contains 288.63 mg lactose
(as monohydrate).
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated tablet.
White, film-coated, round (8 mm) biconvex tablets, scored with a wide
pressure-sensitive
division mark on one side and debossed with ‘M9MN’ and ‘10’ on
the other side.
The tablet can be divided into equal doses.
Pink, film-coated, oval (13.5 x 6.6 mm) biconvex tablets, scored with
a wide pressure-sensitive
division mark on one side and debossed with ‘M9MN 20’ on the other
side.
The tablet can be divided into equal doses.
Yellow, film-coated, oval (8 x 4.5 mm) biconvex tablets, debossed with
‘M9MN 5’ on one side.
White, film
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik inglise 18-07-2018
Toote omadused Toote omadused inglise 18-07-2018